Status:
COMPLETED
Parkinson Disease and DBS: Cognitive Effects in GBA Mutation Carriers
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Parkinson
Parkinson Disease
Eligibility:
All Genders
30-75 years
Brief Summary
Every year, approximately 9,000 Parkinson disease (PD) patients undergo deep brain stimulator (DBS) placement into the subthalamic nucleus (STN-DBS). Studies suggest that PD patients with mutations in...
Detailed Description
Parkinson disease (PD) is a neurodegenerative disease affecting at least 1 million people in the U.S. Each year, 9,000 PD patients undergo deep brain stimulator (DBS) placement into the subthalamic nu...
Eligibility Criteria
Inclusion
- Parkinson's disease
- onset of symptoms under age 60
- at least 5 years of disease
- with OR without deep brain stimulation
Exclusion
- dementia
Key Trial Info
Start Date :
July 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03234478
Start Date
July 1 2017
End Date
June 30 2024
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey, United States, 08901